Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP Helps Cambodia, Southeast Asia Build Arsenal To Combat Counterfeit Drugs

This article was originally published in PharmAsia News

Executive Summary

BEIJING - In the latest moves aimed at fighting counterfeit medicines being sold to patients with malaria or other potentially lethal diseases, the United States Pharmacopeial Convention is training Cambodian scientists to test drugs for quality and authenticity, expanding a new system to track adverse events, and producing television spots to educate the public about the dangers of fake drugs. The USP is conducting a similar offensive against counterfeit drugs throughout Southeast Asia under a cooperative agreement with the United States Agency for International Development

You may also be interested in...



Thailand Joins Forces With Interpol, WHO Taskforce To Fight Invasion Of Counterfeit Drugs

SHANGHAI - Thailand's pharmaceutical industry is helping inform the citizenry about the dangers of counterfeit medicines as the country joins forces with groups including Interpol, the World Health Organization's anti-counterfeiting taskforce, and the United States Pharmacopeia to combat an invasion of fake drugs

Counterfeit Drugs Produced In China Still Threaten Chinese, U.S., Global Consumers

BEIJING - Unless China does more to crack down on counterfeiting and contamination in its pharmaceutical industry, the United States could see a repeat of Chinese-made drugs or raw components causing severe adverse reactions in American hospitals, according to a Washington, D.C.-based scholar

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

SC070062

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel